Regulatory Challenges in the CIS and Russia - TOPRA In CEE WebinarNovember 22, 2023
Inpharmatis and “ACADEMPHARM” Discussed in Minsk Cooperation Opportunities
The Head of the Development Department of Inpharmatis Andrey Berman met in Minsk with representatives of the State Enterprise "ACADEMPHARM" to discuss the prospects for cooperation in the area of drug registration in the EAEU and the European Union.
During the meeting at the International Medical Forum "Health" in Minsk, the parties discussed the prospects for cooperation in pharmacovigilance, registration of medicines, and dietary supplements. Andrey Berman spoke about the experience of Inpharmatis and successfully implemented projects in the markets of Europe, the EAEU, the CIS in the interests of the largest pharmaceutical companies. The parties agreed to exchange detailed information to explore opportunities for cooperation.
"ACADEMPHARM" is a state-owned pharmaceutical enterprise of the Republic of Belarus, which started with the release of 6 drugs, and in 2019 already produced 40 items. As Andrey Berman noted, Inpharmatis has more than 15 years of successful experience in the EAEU, CIS, and Europe and offers a full range of services in regulatory matters, pharmacovigilance, GMP and GDP audit, PIL Readability User Testing, as well as electronic solutions for the pharmaceutical industry and regulatory authorities.
Andrey Berman, Head of the Development Department of Inpharmatis, takes part in the largest International Medical Forum in the Republic of Belarus. The event has been held annually in Minsk for over 25 years, its main goal is the development of the pharmaceutical industry of the Republic of Belarus and the strengthening of international cooperation.
Особенности выбора типа Пользовательского тестирования листка-вкладыша в ЕАЭСNovember 01, 2023
Features of Choosing the Type of PIL RUT in EAEUNovember 01, 2023
PIL Readability User Testing in EAEU Special Autumn OfferOctober 25, 2023
Специальное Осеннее Предложение по пользовательскому тестированию листка-вкладышаOctober 24, 2023
PIL Readability Testing is Mandatory in EAEUFebruary 15, 2022
Пользовательское тестирование по ЕАЭС – обязательная процедураFebruary 14, 2022
One More Inpharmatis Team Member Gets PhD in Pharmaceutical SciencesJanuary 27, 2022
В штате Inpharmatis стало на одного доктора фармацевтических наук большеJanuary 27, 2022
Pharma 4.0: Data-Driven RegulationJanuary 18, 2022